Drug Information Association Logo

Corporate Integrity Agreement and Its Impact on Industry

Time

Wed, Jun 18 7:15AM
W 10

Title

Corporate Integrity Agreement and Its Impact on Industry

Abstract Summary

The study includes an establishment of division to comply with various pharma regulatory acts, enabling through IT / Technologies. This includes but not limited to Sunshine Act, Safe Harbor Act, PhRMA and FDA enforced off label marketing regulations, Sarbans Oxley Act, etc.

Poster Presenter

Abhishek Harde
Consultant,
Cognizant Technology Solutions Corporation
United States